Ruksolitynib w terapii chorych na mielofibrozę — pytania i odpowiedzi

{"title":"Ruksolitynib w terapii chorych na mielofibrozę — pytania i odpowiedzi","authors":"K. Warzocha, W. Homenda, A. Pluta, Tomasz Sacha, M. Cioch, M. Dudziński, D. Krochmalczyk, J. Góra-Tybor, I. Seferynska, M. Joks, M. Sobas","doi":"10.5603/HEM.2018.0035","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":38988,"journal":{"name":"Hematologia","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hematologia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/HEM.2018.0035","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}